Progress Against Stomach Cancer. 1980–1989 Progress Against Stomach Cancer 1980–1989 1980: Combination chemotherapy improves outcomes for advanced stomach.

Slides:

Advertisements

Similar presentations

Breast Cancer Patient Issues in Family Practice: An Interactive Session.

Advertisements

Major Cancer Milestones

Progress Against Breast Cancer

Progress Against Prostate Cancer. 1970–1979 Progress Against Prostate Cancer 1970–1979 Early 1970s: Radioactive ''seeds'' proven effective for prostate.

Progress Against Lung Cancer. 1970–1979 Progress Against Lung Cancer 1970–1979 Mid-1970s: Chemotherapy combinations prove effective in small cell lung.

Progress Against Lymphoma. 1970–1979 Progress Against Lymphoma 1970– : FDA approves doxorubicin, a vital part of combination chemotherapy.

Progress Against Bladder Cancer. Pre-1970 Progress Against Bladder Cancer Pre : Tool offers view inside bladder for first time.

Progress Against Ovarian Cancer. 1970–1979 Progress Against Ovarian Cancer 1970– : First effective combination chemotherapy regimen for ovarian.

Progress Against Testicular Cancer. 1970–1979 Progress Against Testicular Cancer 1970– : Two new drugs produce first complete remissions in advanced.

Progress Against Cervical Cancer. 1980–1989 Progress Against Cervical Cancer 1980– –1984: HPV virus is discovered to cause cervical cancer.

Progress Against Head and Neck Cancer. 1970–1979.

Progress Against Melanoma. 1970–1979 Progress Against Melanoma 1970– : Hereditary syndrome linked to increased melanoma risk.

Progress Against Leukemia. 1970–1979 Progress Against Leukemia 1970– : FDA approves doxorubicin.

Progress Against Kidney Cancer. 1970–1979 Progress Against Kidney Cancer 1970– : Removing just part of the cancerous kidney is proven safe and.

Progress Against Pancreatic Cancer. 1970–1979 Progress Against Pancreatic Cancer 1970– s: Tobacco use found to cause pancreatic cancer.

Progress Against Liver Cancer. 1970–1979 Progress Against Liver Cancer 1970– : First study finds chemotherapy effective for liver cancer.

Presenter Name(s) Issue date National Student.

Case 20 Thomas J. Giordano, M.D., Ph.D.. History A 54-year old man with a past medical history of goiter for approximately 4 years was followed by ultrasound.

AP CALCULUS AB 2012 Question 6 Form A Name_________________ Date __________Period___.

Mammary ductal carcinoma

Trends in incidence and mortality, England 1989 to 2010.

Advances and Emerging Therapy for Lung Cancer

†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.

Oncology The study of cancer. What is cancer? Any malignant growth or tumor caused by abnormal and uncontrolled cell division May be a tumor but it doesn’t.

National Oesophago–Gastric Cancer Audit Comparing local and national figures.

The 70-Gene Profile and Chemotherapy Benefit in 1,600 Breast Cancer Patients Bender RA et al. ASCO 2009; Abstract 512. (Oral Presentation)

Clinical Perspective. Screening/Prevention Who is at risk for what type Decision to Intervene: Risk Assessment normal Evidence of Disease Disability Death.

Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery

Breast Cancer By Kajal Haghmoradi.

The Facts about Breast Cancer

Breast Cancer Shannan McQuade & Ashley Haman. History of Breast Cancer Ancient Egyptians discovered Breast Cancer –Over 3,500 years ago Hippocrates discovered.

By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.

  Surgery  Hormone Therapy  Radiation  Chemotherapy  Immunotherapy  Targeted therapy Methods of Treatment

Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.

Breast Cancer Detection, Treatment, and Survival in Medicare and Medicaid Insured Patients Cathy J. Bradley, Ph.D. Professor of Health Administration Co-leader,

By: Sydney Trecarichi, Hayley Cash and Jordan Wittig Esophageal Cancer.

Eleni Galani Medical Oncologist

BREAST CANCER GROUP 6 :  Nuraini Ikqtiarzune Haryono( )  Tri Wahyu Ningsih ( )  Rani Yuswandaru ( )  Anita Rheza Fitriana Putri( )

Breast Cancer Awareness By: Dominick Phillips. What Is Breast Cancer? If a cell changes into a abnormal, sometimes harmful form, it can divide quickly.

Breast cancer screening Mammography is the most widely used screening modality, with solid evidence of benefit for women aged 40 to 74 years Clinical breast.

 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.

Annual prostate cancer symposium February 23, 2013 The Kimmel Cancer Center, Philadelphia, PA 2nd “ Novel Therapeutic Strategies for Prostate Cancer ”

ER and PR Test Estrogen and Progesterone receptor status tests will show whether or not one or both of these hormones fuel the tumor Cancer that is hormone-sensitive.

Eric Van Cutsem Head, Digestive Oncology, University Hospital Gasthuisberg and Professor of Internal Medicine, University of Leuven, Belgium Published.

Breast Cancer By: Christen Scott.

Treatment Regimens of HER2+ Adjuvant Patients (Actuals) Source: Genentech ASCO 2005 (data release) Nov 2006 (Approval)

Tanisha Shridhar and Kelly Slazinski Mr. Steinman Honors Biology A-2.

Darin Mehlhaf’s Senior Capstone Experience

Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.

Lung Cancer By: Mitch Harbaugh, Michelle Roa, Huba Nasir, Alexandra Ali, Becca Cohen.

S1207: Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients.

S ARCOMA Diana Marroquin Period 1. W HAT IS SARCOMA ? A type of cancer that develops from certain tissues, like bone or muscle that can spread by extension.

Breast Cancer »Breast cancer is a malignant tumor that starts in the cells of the breast. »The disease occurs almost entirely in women,but men can get.

Treatment for Cancer. Surgery Treatment and prognosis depend on severity and spread of the cancer Treatment and prognosis depend on severity and spread.

Breast Cancer in Young Women by Kim Wooden 1. Facts While the majority of women who develop breast cancer are postmenopausal, younger women are more likely.

Patterns of care and comparative effectiveness of endocrine therapy for premenopausal women with early breast cancer A multi-institution cohort study February.

Treatment for Cancer. Surgery Treatment and prognosis depend on severity and spread of the cancer Treatment and prognosis depend on severity and spread.

Statistics (from the National Institutes of Health) on average, in the US, people have a 2 in 5 lifetime risk of developing cancer second leading cause.

Who are Oncologists? The diagnosis, treatment & prevention of cancer is termed as Oncology and Oncologists are doctors who specialise in the treatment.

According to the report, 22% of all cancer deaths are caused due to tobacco. So, it is extremely important to quit consuming tobacco products to prevent.

Short-term outcome of neo-adjuvant chemotherapy

PHEN Clinical Trials Rally

Cervical Cancer Tiffany Smith HCP 102.

S1207: Phase III randomized, placebo-controlled trial adding 1 year of everolimus to adjuvant endocrine therapy for patients with high-risk, HR+, HER2-

Oesophago–Gastric Cancer Audit

Treatment Overview: The Multidisciplinary Team

Neoadjuvant Adjuvant Curative Palliative

Kaplan-Meier (K-M) curves of progression-free survival (PFS) in 54 patients with metastatic gastric cancer treated with RAD001. Kaplan-Meier (K-M) curves.

Presentation transcript:

Progress Against Stomach Cancer

1980–1989

Progress Against Stomach Cancer 1980– : Combination chemotherapy improves outcomes for advanced stomach cancer

Progress Against Stomach Cancer 1980– s: New imaging tools help detect and evaluate stomach cancer

Progress Against Stomach Cancer 1980–1989 Late 1980s: New ultrasound device offers minimally invasive cancer evaluation and treatment tool

Progress Against Stomach Cancer 1980– : Less extensive stomach surgery offers same chance of cure

Progress Against Stomach Cancer 1990–1999

Progress Against Stomach Cancer 1990– : Bacterial infection linked to gastric cancer risk

Progress Against Stomach Cancer 1990– s: Genetic risk factors for gastric cancer are identified

Progress Against Stomach Cancer 1990– : New chemotherapy regimen becomes standard for advanced stomach cancer 1997: Laparoscopy provides less invasive way to assess and treat stomach tumors

Progress Against Stomach Cancer 2000–Present

Progress Against Stomach Cancer 2000–Present 2001: Adjuvant therapy improves long-term survival for patients with early-stage stomach cancer 2001: Gene identified in inherited gastric cancer

Progress Against Stomach Cancer 2000–Present 2000s: Removal of additional lymph nodes shown to help improve survival

Progress Against Stomach Cancer 2000–Present 2006: Chemotherapy before and after surgery improves survival for many patients 2006: New addition to chemotherapy improves survival for select patients

Progress Against Stomach Cancer 2000–Present 2007: Adjuvant chemotherapy alone, without radiation, may be sufficient for early gastric cancer

Progress Against Stomach Cancer 2000–Present 2008: New chemotherapy regimen extends survival for metastatic gastric cancers

Progress Against Stomach Cancer 2000–Present 2010: Common targeted breast cancer drug also improves survival for certain gastric cancers 2011: Korean study affirms value of chemotherapy, alone, following surgery 2012: Adding radiation to chemotherapy after surgery still benefits some patients

Progress Against Stomach Cancer Five-Year Survival Source: National Cancer Institute

Progress Against Stomach Cancer Mortality Source: National Cancer Institute

Progress Against Stomach Cancer New Cases Source: National Cancer Institute

Visit CancerProgress.Net for an interactive timeline of progress against a range of common cancers CancerProgress.Net is a project of the American Society of Clinical Oncology, which represents nearly 30,000 physicians who treat people with cancer and research new cures